Cigna Group (NYSE:CI) Price Target Raised to $305.00 at Wells Fargo & Company

Cigna Group (NYSE:CI) had its price target lifted by Wells Fargo & Company from $300.00 to $305.00 in a report published on Friday morning,Benzinga reports. Wells Fargo & Company currently has an equal weight rating on the health services provider’s stock.

Other analysts also recently issued reports about the stock. Royal Bank Of Canada dropped their target price on shares of Cigna Group from $344.00 to $333.00 and set an “outperform” rating on the stock in a report on Friday, February 6th. Guggenheim reiterated a “buy” rating and issued a $318.00 price target on shares of Cigna Group in a report on Monday, February 2nd. Mizuho set a $325.00 price objective on shares of Cigna Group in a research report on Friday, January 9th. Zacks Research raised shares of Cigna Group from a “strong sell” rating to a “hold” rating in a research report on Monday, January 5th. Finally, Sanford C. Bernstein raised shares of Cigna Group from a “market perform” rating to an “outperform” rating and upped their target price for the stock from $307.00 to $358.00 in a research note on Thursday, March 12th. One research analyst has rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating and four have given a Hold rating to the company’s stock. Based on data from MarketBeat, Cigna Group currently has a consensus rating of “Moderate Buy” and a consensus price target of $336.20.

Cigna Group Trading Down 2.6%

Shares of CI traded down $7.44 during trading hours on Friday, reaching $283.14. The stock had a trading volume of 1,519,233 shares, compared to its average volume of 1,415,385. The company has a market cap of $74.62 billion, a P/E ratio of 12.77, a P/E/G ratio of 1.01 and a beta of 0.26. Cigna Group has a 52 week low of $239.51 and a 52 week high of $350.00. The company has a quick ratio of 0.74, a current ratio of 0.73 and a debt-to-equity ratio of 0.69. The firm has a 50-day moving average of $274.34 and a 200 day moving average of $276.94.

Cigna Group (NYSE:CI) last announced its quarterly earnings results on Thursday, April 30th. The health services provider reported $7.79 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.60 by $0.19. Cigna Group had a return on equity of 19.75% and a net margin of 2.26%.The company had revenue of $68.52 billion during the quarter, compared to the consensus estimate of $66.29 billion. During the same period in the prior year, the company earned $6.74 earnings per share. The company’s revenue for the quarter was up 4.6% compared to the same quarter last year. Cigna Group has set its FY 2026 guidance at 30.350- EPS. On average, sell-side analysts expect that Cigna Group will post 30.35 earnings per share for the current fiscal year.

Cigna Group Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, June 18th. Stockholders of record on Thursday, June 4th will be paid a dividend of $1.56 per share. This represents a $6.24 annualized dividend and a dividend yield of 2.2%. The ex-dividend date of this dividend is Thursday, June 4th. Cigna Group’s dividend payout ratio (DPR) is currently 28.13%.

Insider Buying and Selling

In other Cigna Group news, insider Nicole S. Jones sold 2,307 shares of Cigna Group stock in a transaction on Monday, March 2nd. The shares were sold at an average price of $288.91, for a total value of $666,515.37. Following the sale, the insider directly owned 32,647 shares in the company, valued at approximately $9,432,044.77. The trade was a 6.60% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider Everett Neville sold 1,719 shares of the business’s stock in a transaction dated Monday, March 2nd. The stock was sold at an average price of $288.91, for a total transaction of $496,636.29. Following the sale, the insider directly owned 5,670 shares in the company, valued at $1,638,119.70. This trade represents a 23.26% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. 0.60% of the stock is owned by company insiders.

Institutional Trading of Cigna Group

Several institutional investors and hedge funds have recently bought and sold shares of the stock. Mirae Asset Global Investments Co. Ltd. lifted its stake in Cigna Group by 11.7% in the 3rd quarter. Mirae Asset Global Investments Co. Ltd. now owns 45,235 shares of the health services provider’s stock valued at $13,039,000 after purchasing an additional 4,738 shares during the last quarter. Maj Invest Holding A S increased its position in Cigna Group by 2.4% during the third quarter. Maj Invest Holding A S now owns 422,728 shares of the health services provider’s stock worth $121,854,000 after buying an additional 10,042 shares during the last quarter. Providence Capital Advisors LLC raised its stake in Cigna Group by 1,016.8% in the third quarter. Providence Capital Advisors LLC now owns 8,510 shares of the health services provider’s stock valued at $2,453,000 after buying an additional 7,748 shares during the period. National Pension Service lifted its position in shares of Cigna Group by 3.2% in the third quarter. National Pension Service now owns 683,751 shares of the health services provider’s stock valued at $197,091,000 after buying an additional 21,203 shares during the last quarter. Finally, Banco Bilbao Vizcaya Argentaria S.A. lifted its position in shares of Cigna Group by 13.5% in the third quarter. Banco Bilbao Vizcaya Argentaria S.A. now owns 34,114 shares of the health services provider’s stock valued at $9,839,000 after buying an additional 4,066 shares during the last quarter. Institutional investors own 86.99% of the company’s stock.

Key Stories Impacting Cigna Group

Here are the key news stories impacting Cigna Group this week:

• Positive Sentiment: Cigna reported Q1 results that beat revenue and most EPS expectations, driven by strong Evernorth performance; management raised 2026 adjusted EPS guidance to at least $30.35, supporting upside to valuation. Read More.
• Positive Sentiment: Royal Bank of Canada raised its price target to $337 and kept an “outperform” rating — the move signals bull case support and implies ~19% upside from current levels. Read More.
• Positive Sentiment: Wells Fargo nudged its target to $305 (equal‑weight), a modest endorsement that adds to recent analyst support and narrows downside concerns. Read More.
• Neutral Sentiment: Analyst/think‑piece commentary frames the Q1 beat and Evernorth growth as a case for a higher multiple; these discussions may influence longer‑term sentiment but are not immediate catalysts. Read More.
• Negative Sentiment: Cigna announced it will exit the Affordable Care Act (individual exchange) business in 2027, affecting roughly 369,000 members — the move reduces topline exposure and creates short‑term execution and transition risk. Read More.
• Negative Sentiment: Pharmacy/PBM dynamics remain a watch item: rising pharmacy costs and PBM complexity were highlighted in coverage as potential margin pressure even as Evernorth grows — a risk to future earnings momentum. Read More.
• Negative Sentiment: Some data points are mixed (small EPS/estimate variances reported by some sources) and Quiver/other trackers show notable institutional repositioning and some insider sales in recent periods — data investors watch as a potential signal of rebalancing. Read More.

About Cigna Group

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.